{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:46:05Z","timestamp":1790163965530,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lassa fever, a hemorrhagic fever caused by Lassa virus (LASV), is endemic in West Africa. It is difficult to distinguish febrile illnesses that are common in West Africa from Lassa fever based solely on a patient\u2019s clinical presentation. The field performance of recombinant antigen-based Lassa fever immunoassays was compared to that of quantitative polymerase chain assays (qPCRs) using samples from subjects meeting the case definition of Lassa fever presenting to Kenema Government Hospital in Sierra Leone. The recombinant Lassa virus (ReLASV) enzyme-linked immunosorbant assay (ELISA) for detection of viral antigen in blood performed with 95% sensitivity and 97% specificity using a diagnostic standard that combined results of the immunoassays and qPCR. The ReLASV rapid diagnostic test (RDT), a lateral flow immunoassay based on paired monoclonal antibodies to the Josiah strain of LASV (lineage IV), performed with 90% sensitivity and 100% specificity. ReLASV immunoassays performed better than the most robust qPCR currently available, which had 82% sensitivity and 95% specificity. The performance characteristics of recombinant antigen-based Lassa virus immunoassays indicate that they can aid in the diagnosis of LASV Infection and inform the clinical management of Lassa fever patients.<\/jats:p>","DOI":"10.1038\/s41598-018-24246-w","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T15:06:13Z","timestamp":1523459173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever"],"prefix":"10.1038","volume":"8","author":[{"given":"Matthew L.","family":"Boisen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Goba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mambu","family":"Momoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Demby","family":"Sandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Fullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana K. S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane J.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3079-6500","authenticated-orcid":false,"given":"Megan L.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoliy P.","family":"Koval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla G.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Lachenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7400-4125","authenticated-orcid":false,"given":"Aaron E.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahan","family":"Nekoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Kotliar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Winnicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Siddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gbakie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mbalu","family":"Fonnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica J.","family":"Koroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lansana","family":"Kanneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Kulakosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Hastie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell B.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian G.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onikepe O.","family":"Folarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian T.","family":"Happi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardis C.","family":"Sabeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-7451","authenticated-orcid":false,"given":"Erica Ollmann","family":"Saphire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Humarr","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4329-0795","authenticated-orcid":false,"given":"Donald S.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Schieffelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Garry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"key":"24246_CR1","doi-asserted-by":"publisher","first-page":"e2748","DOI":"10.1371\/journal.pntd.0002748","volume":"8","author":"JG Shaffer","year":"2014","unstructured":"Shaffer, J. G. et al. Lassa fever in post-conflict Sierra Leone. PLoS neglected tropical diseases 8, e2748, https:\/\/doi.org\/10.1371\/journal.pntd.0002748 (2014).","journal-title":"PLoS neglected tropical diseases"},{"key":"24246_CR2","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cell.2015.07.020","volume":"162","author":"KG Andersen","year":"2015","unstructured":"Andersen, K. G. et al. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Cell 162, 738\u2013750, https:\/\/doi.org\/10.1016\/j.cell.2015.07.020 (2015).","journal-title":"Cell"},{"key":"24246_CR3","unstructured":"WHO. Lassa Fever \u2013 Benin, Togo and Burkina Faso. Disease outbreak news 10 March 2017 (2017)."},{"key":"24246_CR4","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3389\/fmicb.2015.01037","volume":"6","author":"JT Manning","year":"2015","unstructured":"Manning, J. T., Forrester, N. & Paessler, S. Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage. Frontiers in microbiology 6, 1037, https:\/\/doi.org\/10.3389\/fmicb.2015.01037 (2015).","journal-title":"Frontiers in microbiology"},{"key":"24246_CR5","unstructured":"ECDC. Lassa fever in Nigeria, Benin, Togo, Germany and USA. European Centre for Disease Prevention and Control 23 March 2016 (2016)."},{"key":"24246_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/vbz.2007.0118","volume":"8","author":"E Fichet-Calvet","year":"2008","unstructured":"Fichet-Calvet, E., Lecompte, E., Koivogui, L., Daffis, S. & ter Meulen, J. Reproductive characteristics of Mastomys natalensis and Lassa virus prevalence in Guinea, West Africa. Vector Borne Zoonotic Dis 8, 41\u201348, https:\/\/doi.org\/10.1089\/vbz.2007.0118 (2008).","journal-title":"Vector Borne Zoonotic Dis"},{"key":"24246_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/15303660160025912","volume":"1","author":"AH Demby","year":"2001","unstructured":"Demby, A. H. et al. Lassa fever in Guinea: II. Distribution and prevalence of Lassa virus infection in small mammals. Vector Borne Zoonotic Dis 1, 283\u2013297 (2001).","journal-title":"Vector Borne Zoonotic Dis"},{"key":"24246_CR8","first-page":"349","volume":"107","author":"DH Walker","year":"1982","unstructured":"Walker, D. H. et al. Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol 107, 349\u2013356 (1982).","journal-title":"Am J Pathol"},{"key":"24246_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1089\/15303660160025903","volume":"1","author":"DG Bausch","year":"2001","unstructured":"Bausch, D. G. et al. Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne Zoonotic Dis 1, 269\u2013281 (2001).","journal-title":"Vector Borne Zoonotic Dis"},{"key":"24246_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","volume":"155","author":"JB McCormick","year":"1987","unstructured":"McCormick, J. B. et al. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155, 445\u2013455 (1987).","journal-title":"J Infect Dis"},{"key":"24246_CR11","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.4269\/ajtmh.1974.23.1140","volume":"23","author":"TP Monath","year":"1974","unstructured":"Monath, T. P., Maher, M., Casals, J., Kissling, R. E. & Cacciapuoti, A. Lassa fever in the Eastern Province of Sierra Leone, 1970\u20131972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg 23, 1140\u20131149 (1974).","journal-title":"Am J Trop Med Hyg"},{"key":"24246_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.antiviral.2007.11.003","volume":"78","author":"SH Khan","year":"2008","unstructured":"Khan, S. H. et al. New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res 78, 103\u2013115, https:\/\/doi.org\/10.1016\/j.antiviral.2007.11.003 (2008).","journal-title":"Antiviral Res"},{"key":"24246_CR13","doi-asserted-by":"publisher","unstructured":"Buba, M. I. et al. Mortality Among Confirmed Lassa Fever Cases During the 2015-2016 Outbreak in Nigeria. American journal of public health, e1\u2013e3, https:\/\/doi.org\/10.2105\/ajph.2017.304186 (2017).","DOI":"10.2105\/ajph.2017.304186"},{"key":"24246_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/bmj.297.6648.584","volume":"297","author":"ME Price","year":"1988","unstructured":"Price, M. E., Fisher-Hoch, S. P., Craven, R. B. & McCormick, J. B. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. Bmj 297, 584\u2013587 (1988).","journal-title":"Bmj"},{"key":"24246_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/1743-422X-8-404","volume":"8","author":"LM Branco","year":"2011","unstructured":"Branco, L. M. et al. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. Virol J 8, 404, https:\/\/doi.org\/10.1186\/1743-422x-8-404 (2011).","journal-title":"Virol J"},{"key":"24246_CR16","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1126\/science.aam7260","volume":"356","author":"KM Hastie","year":"2017","unstructured":"Hastie, K. M. et al. Structural basis for antibody-mediated neutralization of Lassa virus. Science 356, 923\u2013928, https:\/\/doi.org\/10.1126\/science.aam7260 (2017).","journal-title":"Science"},{"key":"24246_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11544","volume":"7","author":"JE Robinson","year":"2016","unstructured":"Robinson, J. E. et al. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits. Nature communications 7, 11544, https:\/\/doi.org\/10.1038\/ncomms11544 (2016).","journal-title":"Nature communications"},{"key":"24246_CR18","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nm.4396","volume":"23","author":"CE Mire","year":"2017","unstructured":"Mire, C. E. et al. Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever. Nat Med 23, 1146\u20131149, https:\/\/doi.org\/10.1038\/nm.4396 (2017).","journal-title":"Nat Med"},{"key":"24246_CR19","doi-asserted-by":"publisher","unstructured":"Plotkin, S. A. Vaccines for epidemic infections and the role of CEPI. Human vaccines & immunotherapeutics, 1\u20138, https:\/\/doi.org\/10.1080\/21645515.2017.1306615 (2017).","DOI":"10.1080\/21645515.2017.1306615"},{"issue":"Suppl 4","key":"24246_CR20","doi-asserted-by":"publisher","first-page":"S750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","volume":"11","author":"JW Huggins","year":"1989","unstructured":"Huggins, J. W. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Rev Infect Dis 11(Suppl 4), S750\u2013761 (1989).","journal-title":"Rev Infect Dis"},{"key":"24246_CR21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1086\/657315","volume":"51","author":"DG Bausch","year":"2010","unstructured":"Bausch, D. G., Hadi, C. M., Khan, S. H. & Lertora, J. J. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis 51, 1435\u20131441, https:\/\/doi.org\/10.1086\/657315 (2010).","journal-title":"Clin Infect Dis"},{"key":"24246_CR22","first-page":"20","volume":"314","author":"JB McCormick","year":"1986","unstructured":"McCormick, J. B. et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 314, 20\u201326 (1986).","journal-title":"Effective therapy with ribavirin. N Engl J Med"},{"key":"24246_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/vim.2014.0108","volume":"28","author":"ML Boisen","year":"2015","unstructured":"Boisen, M. L. et al. Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak. Viral immunology 28, 19\u201331, https:\/\/doi.org\/10.1089\/vim.2014.0108 (2015).","journal-title":"Viral immunology"},{"key":"24246_CR24","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/S0140-6736(85)90752-4","volume":"2","author":"SP Fisher-Hoch","year":"1985","unstructured":"Fisher-Hoch, S. P. et al. Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques. Lancet 2, 1227\u20131229 (1985).","journal-title":"Lancet"},{"key":"24246_CR25","first-page":"429","volume":"52","author":"H Wulff","year":"1975","unstructured":"Wulff, H. & Lange, J. V. Indirect immunofluorescence for the diagnosis of Lassa fever infection. Bull World Health Organ 52, 429\u2013436 (1975).","journal-title":"Bull World Health Organ"},{"key":"24246_CR26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/jcm.20.2.239-244.1984","volume":"20","author":"BS Niklasson","year":"1984","unstructured":"Niklasson, B. S., Jahrling, P. B. & Peters, C. J. Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay. J Clin Microbiol 20, 239\u2013244 (1984).","journal-title":"J Clin Microbiol"},{"key":"24246_CR27","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1128\/JCM.38.7.2670-2677.2000","volume":"38","author":"DG Bausch","year":"2000","unstructured":"Bausch, D. G. et al. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol 38, 2670\u20132677 (2000).","journal-title":"J Clin Microbiol"},{"key":"24246_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/1743-422X-8-478","volume":"8","author":"LM Branco","year":"2011","unstructured":"Branco, L. M. et al. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Virol J 8, 478, https:\/\/doi.org\/10.1186\/1743-422x-8-478 (2011).","journal-title":"Virol J"},{"key":"24246_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/1743-422X-8-314","volume":"8","author":"JN Grove","year":"2011","unstructured":"Grove, J. N. et al. Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Virol J 8, 314, https:\/\/doi.org\/10.1186\/1743-422x-8-314 (2011).","journal-title":"Virol J"},{"key":"24246_CR30","doi-asserted-by":"publisher","first-page":"e1839","DOI":"10.1371\/journal.pntd.0001839","volume":"6","author":"DA Asogun","year":"2012","unstructured":"Asogun, D. A. et al. Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS neglected tropical diseases 6, e1839, https:\/\/doi.org\/10.1371\/journal.pntd.0001839 (2012).","journal-title":"PLoS neglected tropical diseases"},{"key":"24246_CR31","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1128\/jcm.32.12.2898-2903.1994","volume":"32","author":"AH Demby","year":"1994","unstructured":"Demby, A. H., Chamberlain, J., Brown, D. W. & Clegg, C. S. Early diagnosis of Lassa fever by reverse transcription-PCR. J Clin Microbiol 32, 2898\u20132903 (1994).","journal-title":"J Clin Microbiol"},{"key":"24246_CR32","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1128\/JCM.02351-09","volume":"48","author":"S Olschlager","year":"2010","unstructured":"Olschlager, S. et al. Improved detection of Lassa virus by reverse transcription-PCR targeting the 5\u2032 region of S RNA. J Clin Microbiol 48, 2009\u20132013, https:\/\/doi.org\/10.1128\/jcm.02351-09 (2010).","journal-title":"J Clin Microbiol"},{"key":"24246_CR33","doi-asserted-by":"publisher","first-page":"e0003793","DOI":"10.1371\/journal.pntd.0003793","volume":"9","author":"S Nikisins","year":"2015","unstructured":"Nikisins, S. et al. International external quality assessment study for molecular detection of Lassa virus. PLoS neglected tropical diseases 9, e0003793, https:\/\/doi.org\/10.1371\/journal.pntd.0003793 (2015).","journal-title":"PLoS neglected tropical diseases"},{"key":"24246_CR34","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S1473-3099(16)30338-3","volume":"16","author":"RS Dhillon","year":"2016","unstructured":"Dhillon, R. S., Kelly, J. D., Srikrishna, D. & Garry, R. F. Overlooking the importance of immunoassays. The Lancet. Infectious diseases 16, 1109\u20131110, https:\/\/doi.org\/10.1016\/s1473-3099(16)30338-3 (2016).","journal-title":"The Lancet. Infectious diseases"},{"key":"24246_CR35","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1128\/JCM.40.11.4394-4395.2002","volume":"40","author":"C Drosten","year":"2002","unstructured":"Drosten, C., Panning, M., Guenther, S. & Schmitz, H. False-negative results of PCR assay with plasma of patients with severe viral hemorrhagic fever. J Clin Microbiol 40, 4394\u20134395 (2002).","journal-title":"J Clin Microbiol"},{"issue":"Suppl 3","key":"24246_CR36","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1093\/cid\/ciu547","volume":"59","author":"KA Bauer","year":"2014","unstructured":"Bauer, K. A., Perez, K. K., Forrest, G. N. & Goff, D. A. Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis 59(Suppl 3), S134\u2013145, https:\/\/doi.org\/10.1093\/cid\/ciu547 (2014).","journal-title":"Clin Infect Dis"},{"key":"24246_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1743-422X-5-74","volume":"5","author":"LM Branco","year":"2008","unstructured":"Branco, L. M. et al. Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance. Virol J 5, 74, https:\/\/doi.org\/10.1186\/1743-422x-5-74 (2008).","journal-title":"Virol J"},{"key":"24246_CR38","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1128\/JVI.02896-15","volume":"90","author":"KM Hastie","year":"2016","unstructured":"Hastie, K. M. et al. Crystal Structure of the Oligomeric Form of Lassa Virus Matrix Protein Z. J Virol 90, 4556\u20134562, https:\/\/doi.org\/10.1128\/jvi.02896-15 (2016).","journal-title":"J Virol"},{"key":"24246_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","volume":"155","author":"JB McCormick","year":"1987","unstructured":"McCormick, J. B., Webb, P. A., Krebs, J. W., Johnson, K. M. & Smith, E. S. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 155, 437\u2013444 (1987).","journal-title":"J Infect Dis"},{"key":"24246_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00405-010-1370-4","volume":"268","author":"TS Ibekwe","year":"2011","unstructured":"Ibekwe, T. S. et al. Early-onset sensorineural hearing loss in Lassa fever. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 268, 197\u2013201, https:\/\/doi.org\/10.1007\/s00405-010-1370-4 (2011).","journal-title":"European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery"},{"key":"24246_CR41","doi-asserted-by":"publisher","first-page":"954","DOI":"10.4269\/ajtmh.2010.09-0636","volume":"82","author":"AR Trombley","year":"2010","unstructured":"Trombley, A. R. et al. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg 82, 954\u2013960, https:\/\/doi.org\/10.4269\/ajtmh.2010.09-0636 (2010).","journal-title":"Am J Trop Med Hyg"},{"key":"24246_CR42","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3201\/eid1606.100040","volume":"16","author":"M Panning","year":"2010","unstructured":"Panning, M. et al. Laboratory diagnosis of Lassa fever, liberia. Emerg Infect Dis 16, 1041\u20131043, https:\/\/doi.org\/10.3201\/eid1606.100040 (2010).","journal-title":"Emerg Infect Dis"},{"key":"24246_CR43","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1128\/JVI.74.15.6992-7004.2000","volume":"74","author":"MD Bowen","year":"2000","unstructured":"Bowen, M. D. et al. Genetic diversity among Lassa virus strains. J Virol 74, 6992\u20137004 (2000).","journal-title":"J Virol"},{"key":"24246_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4269\/ajtmh.1993.49.214","volume":"49","author":"SG Trappier","year":"1993","unstructured":"Trappier, S. G. et al. Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. Am J Trop Med Hyg 49, 214\u2013221 (1993).","journal-title":"Am J Trop Med Hyg"},{"key":"24246_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.antiviral.2011.02.012","volume":"90","author":"KA Cashman","year":"2011","unstructured":"Cashman, K. A. et al. Evaluation of Lassa antiviral compound ST-193 in a guinea pig model. Antiviral Res 90, 70\u201379, https:\/\/doi.org\/10.1016\/j.antiviral.2011.02.012 (2011).","journal-title":"Antiviral Res"},{"key":"24246_CR46","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.3201\/eid1610.100774","volume":"16","author":"V Amorosa","year":"2010","unstructured":"Amorosa, V. et al. Imported Lassa fever, Pennsylvania, USA, 2010. Emerg Infect Dis 16, 1598\u20131600 (2010).","journal-title":"Emerg Infect Dis"},{"key":"24246_CR47","doi-asserted-by":"crossref","unstructured":"Kitching, A. et al. A fatal case of Lassa fever in London, January 2009. Euro Surveill 14 (2009).","DOI":"10.2807\/ese.14.06.19117-en"},{"key":"24246_CR48","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3201\/eid1205.050052","volume":"12","author":"AM Macher","year":"2006","unstructured":"Macher, A. M. & Wolfe, M. S. Historical Lassa fever reports and 30-year clinical update. Emerg Infect Dis 12, 835\u2013837 (2006).","journal-title":"Emerg Infect Dis"},{"key":"24246_CR49","unstructured":"WHO. Epidemic focus: Lassa Fever. Wkly Epidemiol Rec 91, 265\u2013266 (2016)."},{"key":"24246_CR50","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1038\/nature16041","volume":"528","author":"P Nouvellet","year":"2015","unstructured":"Nouvellet, P. et al. The role of rapid diagnostics in managing Ebola epidemics. Nature 528, S109\u2013116, https:\/\/doi.org\/10.1038\/nature16041 (2015).","journal-title":"Nature"},{"key":"24246_CR51","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S1473-3099(15)00160-7","volume":"15","author":"R Zachariah","year":"2015","unstructured":"Zachariah, R. & Harries, A. D. The WHO clinical case definition for suspected cases of Ebola virus disease arriving at Ebola holding units: reason to worry? The Lancet. Infectious diseases 15, 989\u2013990, https:\/\/doi.org\/10.1016\/s1473-3099(15)00160-7 (2015).","journal-title":"The Lancet. Infectious diseases"},{"key":"24246_CR52","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/S1473-3099(15)00137-1","volume":"15","author":"M Lado","year":"2015","unstructured":"Lado, M. et al. Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. The Lancet. Infectious diseases 15, 1024\u20131033, https:\/\/doi.org\/10.1016\/s1473-3099(15)00137-1 (2015).","journal-title":"The Lancet. Infectious diseases"},{"key":"24246_CR53","doi-asserted-by":"publisher","unstructured":"Boisen, M. L. et al. Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection. J Infect Dis, https:\/\/doi.org\/10.1093\/infdis\/jiw261 (2016).","DOI":"10.1093\/infdis\/jiw261"},{"key":"24246_CR54","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0140-6736(15)61042-X","volume":"386","author":"MJ Broadhurst","year":"2015","unstructured":"Broadhurst, M. J. et al. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet 386, 867\u2013874, https:\/\/doi.org\/10.1016\/s0140-6736(15)61042-x (2015).","journal-title":"Lancet"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24246-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24246-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24246-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:16:51Z","timestamp":1671596211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24246-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24246"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24246-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,12]]},"assertion":[{"value":"16 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Viral Hemorrhagic Fever Consortium (available at: ) is a partnership of academic and industry scientists who are developing diagnostic tests, therapeutic agents, and vaccines for Lassa fever, Ebola, and other severe diseases. Tulane University and its various academic and industry partners have filed US and foreign patent applications on behalf of the consortium for several of these technologies. Technical information may also be kept as trade secrets. If commercial products are developed, consortium members may receive royalties or profits. This does not alter our adherence to all policies of the NIH and <i>Scientific Reports<\/i> on sharing data and materials. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5939"}}